عنوان الدراسة | الجهاز | رقم البروتوكول | الراعي | الحالة | موقع الدراسة |
---|---|---|---|---|---|
An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 5 to less than 18 Years of Age with | 178-CL-206A | Astellas |
مرفوض | N\A | |
"A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination with Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults with Early Rheumatoid Arthritis who |
IM101550 | Bristol-Myers Squibb | منتهي | King Fahad Medical City (Riyadh) | |
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus platinum doublet chemotherapy versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer | CA209-227 | Bristol-Myers Squibb |
منتهي | King Faisal Specialist Hospital and Research Center (Riyadh) | |
"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial with an open-label extension that investigates the effect of the addition of dulaglutide (0.75 and 1.5 mg/week) or placebo weekly to metformin and/or basal insulin on c |
H9X-MC-GBGC | Eli Lilly | جاري | King Khalid University Hospital (Riyadh) | |
"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group study comparing pre-discharge and posT-discharge tReatment initiation with LCZ696 in heArt failure patieNtS with reduced ejectIon-fracTion hospItalized for an acute decOm |
CZ696B2401 | Novartis |
جاري | Saud Al-Babtain Cardiac Center (Dammam) | |
Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subje | 42370 | SFDA | مكتمل | saudi Ajal | |
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Ca | D419AC00003 | AstraZeneca | جاري | King Khalid University Hospital (Riyadh) | |
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 | BAY 94-8862 16244 | Bayer | منتهي | King Abdulaziz University Hospital (Jeddah) | |
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mel | BAY 94-8862 17530 | Bayer | منتهي | King Abdulaziz University Hospital (Jeddah) | |
A three-arm, randomized, open-label, phase II study of everolimus in combination with exemestane versus everolimus alone versus capecitabine in the treatment of postmenupausal women with estrogen receptor postive, locally advanced, recurrent or metastati | CRAD001Y2201 |
Novartis |
مرفوض | N\A |